Introduction: Microbiological research plays a pivotal role in understanding the diverse microbial world and its impact on human health, the environment, various industries, and society as a whole. Collecting and transporting microbial samples accurately and efficiently is crucial for preserving…
Ruhvenile won the Biocon biologics award out of the 3000 applicants from all over India
A collaboration between Ruhvenile Biomedical, India, and RNA Smart Health, Paris, France, aims to develop RNA-based therapeutics to combat COVID-19.
A team, comprising Arockiasamy Arulandu, Sujatha Sunil, and Alessandro Marcello, together with Ruhvenile Biomedical OPC Pvt. Ltd., India, is working to develop novel therapeutics against COVID-19, through the design and synthesis of small, molecular inhibitors specifically targeting SARS-CoV-2 viral replication.
Ruhvenile has been extensively screening small organic compounds to identify non-toxic, non-ionic compounds with validated enveloped-viruses deactivation potential. One potent non-toxic, carbohydrate-based compound has been shown to deactivate different viruses.